Verstegen, Niels J.M.; Hagen, Ruth R.; Kreher, Christine; Kuijper, Lisan H.; van den Dijssel, Jet; Ashhurst, Thomas; Kummer, Laura Y.L.; Cabeza, Virginia Palomares; Steenhuis, Maurice; Duurland, Mariël C.; de Jongh, Rivka; van der Schoot, C. Ellen; Konijn, Veronique A.L.; Mul, Erik; Kedzierska, Katherine; van Dam, Koos P.J.; Stalman, Eileen W.; Boekel, Laura; Wolbink, Gertjan; Tas, Sander W.; Killestein, Joep; Rispens, Theo; Wieske, Luuk; Kuijpers, Taco W.; Eftimov, Filip; van Kempen, Zoé L.E.; van Ham, S. Marieke; ten Brinke, Anja; van de Sandt, Carolien E.; T2B! immunity against SARS-CoV-2 study group
(BMJ Publishing Group, 2024-08-16)
Background Messenger RNA (mRNA) vaccines provide robust protection against SARS-CoV-2 in healthy individuals. However, immunity after vaccination of patients with multiple sclerosis (MS) treated with ocrelizumab (OCR), a ...